- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
CapForce IBD® Breakout Opportunities ETF (BOUT)
The Innovator IBD® Breakout Opportunities ETF (ticker: BOUT) provides investors with exposure to multiple instruments. Access the live BOUT share price, historical performance charts and comprehensive technical analysis to evaluate this ETF against your investment criteria.
Current BOUT share price today: 44.67. Average daily trading volume: %VOLUME% shares on NYSE.
Assess whether the BOUT ETF fits your portfolio by analysing key metrics including dividend yield (where relevant), expense ratio, holdings composition and long-term performance trends. Compare Innovator IBD® Breakout Opportunities asset allocation and underlying exposure against similarly-focused ETFs.
Make faster, more confident investment decisions with InvestingPro's WarrenAI. Ask Warren AI to evaluate BOUT against your specific investment goals, or leverage competitor comparison tools to benchmark performance against peer ETFs. Or sign up free to start tracking BOUT in your personalised watchlist.
Is the Innovator IBD® Breakout Opportunities ETF a Good Investment?
Determining whether the BOUT ETF—or any investment—is a good buy requires comprehensive analysis. To evaluate its potential, you can sign up to InvestingPro, where you can assess share price, fair value and other essential metrics.
Current BOUT share price today: 44.67. Average daily trading volume: %VOLUME% shares on NYSE.
Assess whether the BOUT ETF fits your portfolio by analysing key metrics including dividend yield (where relevant), expense ratio, holdings composition and long-term performance trends. Compare Innovator IBD® Breakout Opportunities asset allocation and underlying exposure against similarly-focused ETFs.
Make faster, more confident investment decisions with InvestingPro's WarrenAI. Ask Warren AI to evaluate BOUT against your specific investment goals, or leverage competitor comparison tools to benchmark performance against peer ETFs. Or sign up free to start tracking BOUT in your personalised watchlist.
Is the Innovator IBD® Breakout Opportunities ETF a Good Investment?
Determining whether the BOUT ETF—or any investment—is a good buy requires comprehensive analysis. To evaluate its potential, you can sign up to InvestingPro, where you can assess share price, fair value and other essential metrics.
NYSE
Currency in USD
Day's Range
44.58
44.76
52 wk Range
35.05
49.41
Day's Range
44.5844.76
52 wk Range
35.0549.41
Key Statistics
- Morning Star Rating
- Risk Rating
- Bid / Ask
- -
- Prev. Close
- 44.91
- Price Open
- 44.76
- Volume
- 1,270
- Average Vol. (3m)
- 2,371
- 1-Year Change
- 17.2522%
- Day’s Range
- 44.58-44.76
- 52-Week Range
- 35.05-49.41
- Market Cap
- 18.04B
- Expense Ratio
- 0.80%
How do you feel today about BOUT?
Vote to see community's results!
orTechnical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Sell
Performance
| TVTX | 7.01% | 65.28 | -1.89% | 16,492 | |
| TGTX | 6.97% | 55.99 | -1.28% | 19,964 | |
Ternium SA ADR | - | 6.93% | - | - | 19,544 |
| HNGE | 6.93% | 92.37 | +1.77% | 12,257 | |
| ELVN | 6.78% | 59.320 | -0.55% | 18,116 | |
| NESR | 6.27% | 34.75 | +0.72% | 28,119 | |
| UBSG | 6.19% | 44.81 | +0.54% | 17,430 | |
| BAC | 6.07% | 62.69 | -0.06% | 15,057 | |
| EMR | 5.93% | 152.82 | +1.74% | 5,908 | |
Embraer SA ADR | - | 5.74% | - | - | 12,229 |
Capital-Force ETF Trust - CapForce IBD Breakout Opportunities ETF is an exchange traded fund launched and managed by M2 Financial LLC. It is co-managed by Penserra Capital Management, LLC. The fund invests in public equity markets of the United States. It invests in stocks of companies operating across diversified sectors. It invests in growth and value stocks of companies across diversified market capitalization. The fund seeks to track the performance of the IBD Breakout Stocks Index, by using full replication technique. Capital-Force ETF Trust - CapForce IBD Breakout Opportunities ETF was formed on September 13, 2018 and is domiciled in the United States.
FAQ
How is the performance of BOUT?
As of 04/09/2026, BOUT is trading at a price of 44.67, with a previous close of 44.91. The stock has fluctuated within a day range of 44.58 to 44.76, while its 52-week range spans from 35.05 to 49.41.
What is the current price of BOUT?
The BOUT stock price today is 44.67.
Does BOUT Pay Dividends? What’s The Current Dividend Yield?
The Innovator IBD® Breakout Opportunities dividend yield is 0.28%.
What is the BOUT expense ratio?
The expense ratio for BOUT is 0.80%.
What is the BOUT premarket price?
BOUT's last pre-market stock price is 44.91.
What is the BOUT after hours price?
BOUT's last after hours stock price is 44.67.
What is the P/E ratio of BOUT?
The P/E ratio for BOUT is 5.61.
What is BOUT?
BOUT is an ETF issued by Capital-FORCE ETF and is listed and traded on the New York Stock Exchange.
From a Technical Analysis Perspective, Is BOUT a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
What is the BOUT market cap?
The market cap for BOUT is 18.04B.
When is the BOUT dividend date?
The next dividend date for BOUT is 31/12/2025.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.